N-Feruloylhistamine

N-Feruloylhistamine is a naturally occurring imidazole alkaloid and phenolic amide derivative, primarily identified as a bioactive constituent in the roots of the Ephedra plant (known as Maōkon in traditional medicine) and other species such as Salsola collina (Hikino et al., 1983). It is not a therapeutic target protein or receptor itself; rather, it is a bioactive small molecule identified as a 'hypotensive principle' due to its reported ability to lower blood pressure in animal models (Hikino et al., 1984). Biologically, N-Feruloylhistamine functions as an anti-allergic and anti-inflammatory agent, specifically by inhibiting the degranulation of mast cells and the subsequent release of histamine (Miao et al., 2020). Furthermore, research has demonstrated that it can inhibit tyrosinase activity, the rate-limiting enzyme in melanin synthesis, which suggests potential applications in the management of hyperpigmentation disorders (PubChem CID 10401784). While it possesses various pharmacological properties, it is categorized as a phytochemical ligand or natural product rather than a traditional drug target like a receptor, enzyme, or transporter.

Other names

FeruloylhistamineN-trans-FeruloylhistamineN-[2-(1H-imidazol-4-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide

N-Feruloylhistamine acts as a bioactive ligand rather than a target; it inhibits tyrosinase activity to reduce melanogenesis and suppresses the release of histamine from mast cells by inhibiting degranulation. It also exhibits hypotensive effects by modulating vascular resistance, although its specific protein-binding sites for these effects have not been formally characterized as therapeutic targets.